Large scale Mammalian plant design from 1980’s to present day Dave WoltonVP manufacturing1
OverviewCMC
Development of Large scale Mammalian Monoclonal factories
1985-1990
1990-1995
1995-2006
Present day
Next Generation Factories
Impact of the new design on the rest of the organisation
CMC prototyping of disposable harvest systems
Summary2
CMC Biologics – Overview    Target & Lead ID    Pre-toxToxPhase I Phase II Phase IIICommercial ProductionCMC BiologicsContract Manufacturer of Biological Therapeutics utilizing MAMMALIAN & MICROBIAL CELL CULTURE TECHNOLOGIESCell-line Development – CHEF1™ technology
 Upstream/Downstream – process development and manufacture
Analysis, Characterization, Formulation, Quality and Regulatory3
Development of Large scale Mammalian Monoclonal factories Late 80’s4
Late 80’sThe dawn of automationSimple semi manual fermentorsValidation becoming more involvedContainment being actively pursuedCIP/SIP systems becoming more complicatedAutomation seen as reducing Headcount, Turn-round timeOperator errors5
Early 90’s6
Early 90’sSome companies begin to realise complex automation systems have drawbacks. They see increasing HeadcountComplexity of plantTurn-round timesComplexity of investigations (variables)Facility build costsFacility construction times7
Early 90’sExample of early 90’s BioreactorAdditive manifoldAir OutAir to headspaceAir to spargerJacket heat exchangerSample device8
Late 90’s to 20069
Late 90’s to 2006Some companies start to reduce cost by simplifying.Stainless steel reactors are simplified by reducing numbers of valves/items.Disposables reduce the need for CIP/SIP. InnovationsTubing weldersLynx valvesPod filtersWave reactorsSUM’s10
The fastest CIP?  Reduce the number of inlets that need cleaning.How to simplify stainless vessels11
How to simplify stainless vesselsAdditive manifolds12
How to simplify stainless vesselsAir Out13
How to simplify stainless vesselsAir To Head Space14
How to simplify stainless vesselsAir To Sparger15
How to simplify stainless vessels16Number of sterile boundary elastomersPre Lynx ModificationsApproximately 70Post Lynx modificationsApproximately 30
Present Day17
Single use bioreactors18
Present dayElan’s plant design breaks new ground (2008).Large scale disposables are widely accepted2000L reactors are launched onto the market (2010)19
Next generation factories20
The Facility – the next generation of plant after élan2g/l  monoclonal antibody- fed batch10 x 4,000L batches per month80 cm column, 3 cycles = 2 x 12,000L stainless plant21
The Facility – The next generation after ÉlanFoot print ComparisonPurificationBioreactors.XXBuffer prep.Media prep.22
The Facility – the next generation of plant after élanHow do you make media next to the bioreactor without contaminating the room with powder?23
Contained media mixing – GEA24
Contained media mixing – HycloneHyclonePowdertainer25
Contained media mixing - Lormac26
Use of Buffer towers in Downstream  worked example27
The Facility – the next generation of plant after élanHow do you make and store up to 6,000L of buffer and not use large numbers of buffer bags?28
Buffer towers - PrototypeAnswerBy positioning 2,000L buffer towers close to the column and ‘topping up’ from 1,000L single use mixers.Prototype29
Buffer towers - worked exampleBuffer ModelingBuffer storage in 1000L Buffer hold bags VS Five 2,000L buffer towers; replaced monthlyBuffer b Adsorption chromatography buffer -  Max 4,000LBuffer a  UltrafiltrationDiafiltration buffer – Max 6,000L30
The Facility – the next generation of plant after élanBuffer bBuffer a31

Seattle presentation

  • 1.
    Large scale Mammalianplant design from 1980’s to present day Dave WoltonVP manufacturing1
  • 2.
  • 3.
    Development of Largescale Mammalian Monoclonal factories
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
    Impact of thenew design on the rest of the organisation
  • 10.
    CMC prototyping ofdisposable harvest systems
  • 11.
  • 12.
    CMC Biologics –Overview Target & Lead ID Pre-toxToxPhase I Phase II Phase IIICommercial ProductionCMC BiologicsContract Manufacturer of Biological Therapeutics utilizing MAMMALIAN & MICROBIAL CELL CULTURE TECHNOLOGIESCell-line Development – CHEF1™ technology
  • 13.
    Upstream/Downstream –process development and manufacture
  • 14.
  • 15.
    Development of Largescale Mammalian Monoclonal factories Late 80’s4
  • 16.
    Late 80’sThe dawnof automationSimple semi manual fermentorsValidation becoming more involvedContainment being actively pursuedCIP/SIP systems becoming more complicatedAutomation seen as reducing Headcount, Turn-round timeOperator errors5
  • 17.
  • 18.
    Early 90’sSome companiesbegin to realise complex automation systems have drawbacks. They see increasing HeadcountComplexity of plantTurn-round timesComplexity of investigations (variables)Facility build costsFacility construction times7
  • 19.
    Early 90’sExample ofearly 90’s BioreactorAdditive manifoldAir OutAir to headspaceAir to spargerJacket heat exchangerSample device8
  • 20.
  • 21.
    Late 90’s to2006Some companies start to reduce cost by simplifying.Stainless steel reactors are simplified by reducing numbers of valves/items.Disposables reduce the need for CIP/SIP. InnovationsTubing weldersLynx valvesPod filtersWave reactorsSUM’s10
  • 22.
    The fastest CIP? Reduce the number of inlets that need cleaning.How to simplify stainless vessels11
  • 23.
    How to simplifystainless vesselsAdditive manifolds12
  • 24.
    How to simplifystainless vesselsAir Out13
  • 25.
    How to simplifystainless vesselsAir To Head Space14
  • 26.
    How to simplifystainless vesselsAir To Sparger15
  • 27.
    How to simplifystainless vessels16Number of sterile boundary elastomersPre Lynx ModificationsApproximately 70Post Lynx modificationsApproximately 30
  • 28.
  • 29.
  • 30.
    Present dayElan’s plantdesign breaks new ground (2008).Large scale disposables are widely accepted2000L reactors are launched onto the market (2010)19
  • 31.
  • 32.
    The Facility –the next generation of plant after élan2g/l monoclonal antibody- fed batch10 x 4,000L batches per month80 cm column, 3 cycles = 2 x 12,000L stainless plant21
  • 33.
    The Facility –The next generation after ÉlanFoot print ComparisonPurificationBioreactors.XXBuffer prep.Media prep.22
  • 34.
    The Facility –the next generation of plant after élanHow do you make media next to the bioreactor without contaminating the room with powder?23
  • 35.
  • 36.
    Contained media mixing– HycloneHyclonePowdertainer25
  • 37.
  • 38.
    Use of Buffertowers in Downstream worked example27
  • 39.
    The Facility –the next generation of plant after élanHow do you make and store up to 6,000L of buffer and not use large numbers of buffer bags?28
  • 40.
    Buffer towers -PrototypeAnswerBy positioning 2,000L buffer towers close to the column and ‘topping up’ from 1,000L single use mixers.Prototype29
  • 41.
    Buffer towers -worked exampleBuffer ModelingBuffer storage in 1000L Buffer hold bags VS Five 2,000L buffer towers; replaced monthlyBuffer b Adsorption chromatography buffer - Max 4,000LBuffer a UltrafiltrationDiafiltration buffer – Max 6,000L30
  • 42.
    The Facility –the next generation of plant after élanBuffer bBuffer a31